Cheyne Capital Management (UK) LLP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 181 filers reported holding NEKTAR THERAPEUTICS in Q4 2015. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2015$1,889,000
-56.0%
172,306
-49.9%
0.89%
-36.3%
Q2 2015$4,298,000
-33.7%
343,670
-41.7%
1.39%
-11.0%
Q1 2015$6,479,000
+19.9%
589,260
+69.1%
1.56%
+9.9%
Q4 2014$5,402,000
+94.9%
348,419
+51.8%
1.42%
+43.8%
Q3 2014$2,772,000229,5770.99%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2015
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders